dokumendiregister.ee
OtsingAsutusedMCP
Otsing›Sotsiaalministeerium
Sissetulev kiriAvalik

Pöördumine

Sotsiaalministeerium · 1. detsember 2020
Viit
1.4-2/3467-1
Registreeritud
1. detsember 2020
Dokumendi liik
Sissetulev kiri
Adressaat
WHO
Saabumis/saatmisviis
e-post
Funktsioon
1.4 EL otsustusprotsess ja rahvusvaheline koostöö
Sari
1.4-2 Rahvusvahelise koostöö korraldamisega seotud kirjavahetus (Arhiiviväärtuslik)
Toimik
1.4-2/2020
Vastutaja
Hanna Alajõe (Sotsiaalministeerium, Kantsleri vastutusvaldkond, Euroopa Liidu ja väliskoostöö osakond)
Lahendamise tähtaeg
31. detsember 2020

Failid

  • 📎E-kiri.pdf76 KB
  • 📎EST MR lab accreditation letter signed Nov20.pdf371 KB
  • 📎Estonia, MR summary of review 2019.pdf185 KB

Sisu (failidest)

WORLD HEALTH ORGANIZATION ORGANISATION MONDIALE DE LA SANTÉ WELTGESUNDHEITSORGANISATION Date: 26 November 2020 ВСЕМИРНАЯ ОРГАНИЗАЦИЯ ЗДРАВООХРАНЕНИЯ . . REGIONAL OFFICE FOR EUROPE BUREAU RÉGIONAL DE L’EUROPE Mr Tanel Kiik REGIONALBÜRO FÜR EUROPA ЕВРОПЕЙСКОЕ РЕГИОНАЛЬНОЕ БЮРО Minister of Social Affairs Ministry of Social Affairs Head office: Suur-Ameerika 1 UN City, Marmorvej 51, DK-2100 Copenhagen Ø, Denmark Tallinn 10129 Tel.: +45 45 33 70 00; Fax: +45 45 33 70 01 Estonia Email: [email protected] . . Website: http://www.euro.who.int Our reference: Your reference: Notre référence: Votre référence: Unser Zeichen: Ihr Zeichen: См. наш номер: На Ваш номер: Dear Sir, As part of the annual accreditation procedure, the National Measles/Rubella Laboratory of your country was reviewed during the second quarter of 2020 by the WHO Regional Office for Europe. Based on the results of this review, I am pleased to inform you that the National Laboratory is fully accredited as a WHO Measles/Rubella National Laboratory for 2021 for measles and rubella serology, molecular detection and measles virus sequencing. Enclosed are the scope of the accreditation and the recommendations of the review for your information. The COVID-19 pandemic and response has had an exceptional impact on health systems in the WHO European Region. While acknowledging the demands and challenges posed by COVID-19, I urge all countries to ensure the continuity of measles and rubella surveillance, including high-quality epidemiological and laboratory investigation of cases at the level required for measles and rubella elimination. We cannot afford to let down our guard against measles and rubella, especially in the midst of this global public health emergency. I take this opportunity to thank you personally for your ongoing support for the National Measles/Rubella Laboratory and to congratulate the staff of the Laboratory on the successful accreditation. Yours very truly, Dr Hans Henri P. Kluge Regional Director UN City, Marmorvej 51 Tel.: +45 45 33 70 00 Email: [email protected] DK-2100 Copenhagen Ø Fax: +45 45 33 70 01 Website: http://www.euro.who.int Denmark Copy for information to: Ms Elen Ohov, Adviser, European Union Affairs and International Co-operation Department Ministry of Social Affairs, Suur-Ameerika 1, Tallinn 10122, Estonia Ms Triin Uusberg, Head, European and International Coordination Department, Ministry of Social Affairs, Suur- Ameerika 1, Tallinn 10129, Estonia H.E. Ms Katrin Saarsalu-Layachi, Ambassador Extraordinary and Plenipotentiary, Permanent Representative, Permanent Mission of the Republic of Estonia to the United Nations Office and other international organizations in Geneva, Chemin du Petit-Saconnex 28A, Genève CH-1209, Switzerland H.E. Mr William Mart Laanemäe, Ambassador Extraordinary and Plenipotentiary, Embassy of the Republic of Estonia, Frederiksgade 19, 4th floor, Copenhagen K 1265, Denmark Ms Kristina Köhler, Liaison Officer, WHO Country Office, Estonia, Paldiski Road 81, Tallinn 10617, Estonia –2– Measles and Rubella National Laboratory or sub-National Laboratory Check- list for WHO Accreditation Section 1: General Review & Overall Findings Dates of 01/01/2019 – On-site / Desk Review Accreditation for Review: 31/12/2019 calendar year: 2021 Name of Health Board Laboratory of Communicable Diseases Laboratory: Address: Paldiski mnt 81, 10617 Tallinn Country ESTONIA Phone: +372 7943638 Email: [email protected] Website: www.terviseamet.ee Head of Institute: Merike Jürilo Head of Department: Külli Rae Head of Measles and Liidia Dotsenko Rubella Laboratory: Technical Supervisor: Liidia Dotsenko Number of laboratories under supervision: 1 Name of Reviewer(s): Dr. Myriam Ben Mamou & Dovile Videbaek, WHO/Europe Name of National Accreditation Authority (if appropriate) and current accreditation status from this authority (e.g. ISO15189 or other, provide documentation): Estonian Accreditation Centre, ISO13189, Accreditation certificate M004 (http://eak.ee/dokumendid/pdf/kasitlusala/M004.pdf) 1 Summary of Accreditation Review Recommendations (check one): Accredit: Laboratory meets all criteria Measles: Rubella: Serology Serology Detection RT-PCR/RT-qPCR Detection RT-PCR/RT-qPCR Sequencing Sequencing Cell Culture Cell Culture Measles testing not done Rubella testing not done Provisionally accredit: Laboratory passed the most recent proficiency test, but needs to strengthen one or more of the remaining criteria (check off relevant criteria): Measles: Rubella: Serology Serology Detection RT-PCR/RT-qPCR Detection RT-PCR/RT-qPCR Sequencing Sequencing Cell Culture Cell Culture Measles testing not done Rubella testing not done Do not accredit: Laboratory did not pass the most recent proficiency test and/or did not meet other performance indicators. Measles: Rubella: Serology Serology Detection RT-PCR/RT-qPCR Detection RT-PCR/RT-qPCR Sequencing Sequencing Cell Culture Cell Culture Measles testing not done Rubella testing not done 2 Main General Findings: Findings: Confirmatory test results of Sub-national Laboratories’ referred specimens are reported 1. 100% within 14 days for ≥ 80% of specimens received: Completeness: 100% 2. The laboratory reports monthly to WHO: Timeliness: 92% 3. IgM tests are performed on at least 50 specimens annually: Measles: 221 Rubella: 191 Measles and Rubella IgM test results conducted for primary 4. diagnostics are reported by the laboratory within 4 days of Measles: 94% receipt, for ≥ 80% of specimens Rubella: 94% The accuracy of IgM detection is ≥ 90% (NLs sending sera to Measles: 100% 5. RRL and SNLs to NLs for confirmatory testing) - Rubella: 100% 43 measles and 8 rubella samples Molecular tests are performed on at least 2 specimens per quarter, for measles and Yes - measles 6. rubella (RT-PCR, GT) NA - rubella Score on most recent WHO Serology proficiency test is ≥ 90%: 7. Measles: 100% PT panel number: 01901 Date reported: 30/10/2019 Rubella: 97.5% Performance on most recent WHO Molecular EQA Measles Mol detection: Passed is passed (P) /re-test (R) (provisionally passed)/fail (F) Measles Sequencing: Passed 8. Panel number for measles: 19-1 Date reported: 27/11/2019 Rubella Mol detection: NA Panel number for rubella: Date reported: dd/mm/yyyy Rubella Sequencing: NA For labs that conduct virus sequencing: Virus sequencing is completed AND reported to WHO through MeaNS or RubeNS within 2 months of MeaNS; 48% (11/23)* 9. receipt of specimens, for ≥80% of the specimens appropriate for genetic RubeNS: NA analysis 10. Score from on-site review of laboratory operating procedures and practices is ≥ 80%: *Due to shortage of staff sequences of 2019 were submitted with delay. Key accreditation criteria 7- The laboratory should use in-house control for rubella EIA. 9- Laboratory is reminded to submit sequences to MeaNS in a timely manner. Conclusion • Good performance for serology and measles RT-PCR & sequencing 3 Saatja: ABDUSALYAMOVA, Malika <[email protected]> Saadetud: 01.12.2020 13:49 Adressaat: Tanel Kiik <[email protected]>; Triin Uusberg <[email protected]> Koopia: Elen Ohov <[email protected]>; Triin Uusberg <[email protected]>; SM Info <[email protected]>; <[email protected]>; <[email protected]>; <[email protected]>; <[email protected]>; KÖHLER, Kristina <[email protected]>; BEN MAMOU, Myriam Corinne <[email protected]>; VIDEBAEK, Dovile <[email protected]> Teema: Accreditation for 2020 of the WHO National Reference Laboratory for Measles and Rubella Please see the attached correspondence sent from the World Health Organization, Regional Office for Europe. One or more attachments may be included.Veuillez vous r¨¦f¨¦rer ¨¤ la correspondance ci-jointe du Bureau r¨¦gional de l'Europe de l'Organisation mondiale de la sant¨¦. Une ou plusieurs annexes peuvent ¨ºtre jointes.Mit der Bitte um Kenntnisnahme der beiliegenden Korrespondenz (eine oder mehrere Anlagen), Weltgesundheitsorganisation, Regionalb¨¹ro f¨¹r Europa.§³§Þ. §á§â§Ú§Ü§â§Ö§á§Ý§Ö§ß§ß§í§Ö §á§Ú§ã§î§Þ§Ñ §à§ä §¦§Ó§â§à§á§Ö§Û§ã§Ü§à§Ô§à §â§Ö§Ô§Ú§à§ß§Ñ§Ý§î§ß§à§Ô§à §Ò§ð§â§à §£§ã§Ö§Þ§Ú§â§ß§à§Û §à§â§Ô§Ñ§ß§Ú§Ù§Ñ§è§Ú§Ú §Ù§Õ§â§Ñ§Ó§à§à§ç§â§Ñ§ß§Ö§ß§Ú§ñ (§à§Õ§Ú§ß §Ú§Ý§Ú §ß§Ö§ã§Ü§à§Ý§î§Ü§à §á§â§Ú§Ü§â§Ö§á§Ý§Ö§ß§ß§í§ç §æ§Ñ§Û§Ý§à§Ó). &nbsp;
Allikas: Sotsiaalministeerium dokumendiregister →
dokumendiregister.eeAsutusedEesti avalike dokumendiregistrite otsing · nimistu.ee andmetel